Strides Pharma Science, an Indian pharmaceutical company, is set to demerge its contract development and manufacturing organisation into an independent and publicly-traded company. “We expect this company to be formed through the NCLT process in the next 12 to 18 months considering that there are multiple companies being merged and demerged into the structure," Arun Kumar, Strides Pharma Executive Chairperson and Managing Director.